Anpassung der Pharmakovigilanz im Rahmen der COVID-19-Impfkampagne

This procedure is a written inquiry regarding the monitoring of drug safety and adverse reactions (pharmacovigilance) during the COVID-19 vaccination rollout. It seeks to clarify how safety data was collected and analyzed to ensure public health protection. This affects healthcare providers, regulatory authorities, and the general public by examining the transparency and effectiveness of vaccine safety monitoring.